Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com

Skip over primary navigation

EUDRAGIT® | HOMEEUDRAGIT® | HOME
  • About EUDRAGIT®About EUDRAGIT®
  • Products & servicesProducts & services
  • Workshops & eventsWorkshops & events
  • DownloadsDownloads
  • e-Labe-Lab
  • ContactContact

Skip over visual

Skip over functional column



Skip over functional column

EUDRAGIT® - Functional polymers for protective, enteric and sustained-release formulations

  • Products & services
  • EUDRAGIT® products
  • Sustained-release formulations
  • EUDRAGIT® RL PO

EUDRAGIT® RL PO

EUDRAGIT® RL PO is a copolymer of ethyl acrylate, methyl methacrylate and a low content of methacrylic acid ester with quaternary ammonium groups. The ammonium groups are present as salts and make the polymers permeable.

Physical properties: It is a solid substance in form of white powder with a faint amine-like odour.

Chemical structure:

 

 

 

 

 

 

 

Product Form: Powder
Targeted Drug Release Area: Time controlled release, pH independent
Dissolution:

  • Insoluble
  • High permeability
  • pH independent swelling

 

Characteristics:

  • Customized release profile by combination of RL and RS grades in different ratios
  • Suitable for matrix structures

 

CAS number: 33434 – 24 – 1
Chemical/IUPAC name: Poly(ethyl acrylate-co-methyl methacrylate-co-trimethylammonioethyl methacrylate chloride) 1:2:0.2
INCI name: Acrylates / Ammonium Methacrylate Copolymer

Monographs:

        Ph. Eur.: Ammonio Methacrylate Copolymer, Type A
        USP/NF: Ammonio Methacrylate Copolymer, Type A - NF
        JPE: Aminoalkyl Methacrylate Copolymer RS

GMP standard: The Joint IPEC – PQG Good Manufacturing Practice
Guide for Bulk Pharmaceutical Excipients 2006 and
USP-NF General Chapter <1078>


Drug Master File: # 1242
Weight average molar mass: approx. 32,000 g/mol
Alkali Value: 28,1 mg KOH/ g polymer
Glass Transition Temperature (Tg): ~70°C

An according EIP format is available on request.

Pharmacopoeial Monographs

more

Other Sustained-Release Formulations
  • EUDRAGIT® RL 100
  • EUDRAGIT® RL 30 D
  • EUDRAGIT® RL 12,5
  • EUDRAGIT® RS 100
  • EUDRAGIT® RS PO
  • EUDRAGIT® RS 30 D
  • EUDRAGIT® RS 12,5
  • EUDRAGIT® NE 30 D
  • EUDRAGIT® NE 40 D
  • EUDRAGIT® NM 30 D
 

Overview

Business model
News

Overview

EUDRAGIT® products
  • Enteric formulations
    • EUDRAGIT® L 30 D-55
    • EUDRAGIT® L 100-55
    • EUDRAGIT® L 100
    • EUDRAGIT® L 12,5
    • EUDRAGIT® S 100
    • EUDRAGIT® S 12,5
    • EUDRAGIT® FS 30 D
  • Protective formulations
    • EUDRAGIT® E 100
    • EUDRAGIT® E 12,5
    • EUDRAGIT® E PO
  • Sustained-release formulations
    • EUDRAGIT® RL 100
    • EUDRAGIT® RL PO
    • EUDRAGIT® RL 30 D
    • EUDRAGIT® RL 12,5
    • EUDRAGIT® RS 100
    • EUDRAGIT® RS PO
    • EUDRAGIT® RS 30 D
    • EUDRAGIT® RS 12,5
    • EUDRAGIT® NE 30 D
    • EUDRAGIT® NE 40 D
    • EUDRAGIT® NM 30 D
  • PlasACRYL™ T20
Technical support
  • Laboratories worldwide
    • Laboratories in China
    • Laboratories in Germany
    • Laboratories in India
    • Laboratories in Japan
    • Laboratories in the USA
Formulation development
GMP services
  • GMP facilities in Germany
Proof of concept
Advanced drug delivery

Overview

Workshops
Trade shows
Webinars

Overview

Pharma Polymers News
EUDRAGIT® Quickstarts
Brochures
Scientific posters
Product specifications
Other downloads

Overview

Open the e-Lab
What is the e-Lab?
 
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page